Translational atherosclerosis research: From experimental models to coronary artery disease in humans
Abstract Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the past two decades. However, despite great advances there is still a lack of therapies that reduce adverse cardiovascular events to an...
Saved in:
Published in | Atherosclerosis Vol. 248; pp. 110 - 116 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the past two decades. However, despite great advances there is still a lack of therapies that reduce adverse cardiovascular events to an acceptable degree. This review addresses successes, but also questions, challenges, and chances regarding the translation of basic science results into clinical practice, i.e. the capability to apply the results of basic and/or clinical research in order to design therapies suitable to improve patient outcome. Specifically, it discusses problems in translating findings from the most broadly used murine models of atherosclerosis into clinically feasible therapies and strategies potentially improving the results of clinical trials. Most likely, the key to success will be a multimodal approach employing novel imaging methods as well as large scale screening tools–summarized as “omics” approach. Using individually tailored therapies, plaque stabilization and regression could prevent adverse cardiovascular events thereby improving outcome of a large number of patients. |
---|---|
AbstractList | Abstract Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the past two decades. However, despite great advances there is still a lack of therapies that reduce adverse cardiovascular events to an acceptable degree. This review addresses successes, but also questions, challenges, and chances regarding the translation of basic science results into clinical practice, i.e. the capability to apply the results of basic and/or clinical research in order to design therapies suitable to improve patient outcome. Specifically, it discusses problems in translating findings from the most broadly used murine models of atherosclerosis into clinically feasible therapies and strategies potentially improving the results of clinical trials. Most likely, the key to success will be a multimodal approach employing novel imaging methods as well as large scale screening tools–summarized as “omics” approach. Using individually tailored therapies, plaque stabilization and regression could prevent adverse cardiovascular events thereby improving outcome of a large number of patients. Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the past two decades. However, despite great advances there is still a lack of therapies that reduce adverse cardiovascular events to an acceptable degree. This review addresses successes, but also questions, challenges, and chances regarding the translation of basic science results into clinical practice, i.e. the capability to apply the results of basic and/or clinical research in order to design therapies suitable to improve patient outcome. Specifically, it discusses problems in translating findings from the most broadly used murine models of atherosclerosis into clinically feasible therapies and strategies potentially improving the results of clinical trials. Most likely, the key to success will be a multimodal approach employing novel imaging methods as well as large scale screening tools–summarized as “omics” approach. Using individually tailored therapies, plaque stabilization and regression could prevent adverse cardiovascular events thereby improving outcome of a large number of patients. •Despite great advances, therapies reducing adverse cardiovascular events are scarce.•Animal models help to understand some aspects of atherogenesis.•Animal models do not perfectly reflect human pathology.•To improve anti-atherosclerotic therapy, a multimodal approach will be necessary. Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the past two decades. However, despite great advances there is still a lack of therapies that reduce adverse cardiovascular events to an acceptable degree. This review addresses successes, but also questions, challenges, and chances regarding the translation of basic science results into clinical practice, i.e. the capability to apply the results of basic and/or clinical research in order to design therapies suitable to improve patient outcome. Specifically, it discusses problems in translating findings from the most broadly used murine models of atherosclerosis into clinically feasible therapies and strategies potentially improving the results of clinical trials. Most likely, the key to success will be a multimodal approach employing novel imaging methods as well as large scale screening tools-summarized as "omics" approach. Using individually tailored therapies, plaque stabilization and regression could prevent adverse cardiovascular events thereby improving outcome of a large number of patients. |
Author | Gleissner, Christian A |
Author_xml | – sequence: 1 fullname: Gleissner, Christian A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26999293$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1rFTEUxYNU7Gv1X5BsBDcz3nzMRwQFKbYVCi6s65CX3PDynJk8k5li_3szvNbFW7nJhXDOuZzfvSBnU5yQkHcMagas_bCvzbzDFLMd1jfkmpfvGkQNTLwgG9Z3qmKyl2dkA8BZpVgD5-Qi5z0AyI71r8g5b5VSXIkNwftkpjyYOcTJDPQkmybMaJLdfaTXKY4U_xwwhRGnuWjH6HDIdI7UxlTc6ZGaNGMZLhRXRhomulvGkv-avPRmyPjmaV6Sn9df769uq7vvN9-uvtxVVko5V9z0HBx2tm0BjOJ8KzveCcUk443xlm-9g2brwVjeNx6clY3rvZLGGK-MF5fk_TH3kOLvBfOsx5AtDoOZMC5Zs67nnLVSQJF-OkptaZoTen0ozUoJzUCvpPVen9DQK2kNQhfSxf_2adWyHdH9cz-jLYKbo6BAwoeASWcbcLLoQkI7axfDf6_6fJJkhzAFa4Zf-Ih5H5dUblfa6cw16B_r2ders1YA9D2Iv6y-ssY |
CitedBy_id | crossref_primary_10_1186_s12918_018_0579_5 crossref_primary_10_1016_j_carpath_2017_11_004 crossref_primary_10_3233_BIR_190215 crossref_primary_10_1089_hum_2017_129 crossref_primary_10_3389_fphys_2020_00673 crossref_primary_10_33218_prnano2_1__181114_1 crossref_primary_10_4244_EIJV12I1A2 crossref_primary_10_1186_s12944_022_01714_x crossref_primary_10_1016_j_atherosclerosis_2019_05_009 crossref_primary_10_1161_CIRCRESAHA_116_309326 crossref_primary_10_3390_biomedicines10071715 crossref_primary_10_1002_jcp_27317 crossref_primary_10_4062_biomolther_2016_275 |
Cites_doi | 10.1016/S0021-9150(00)00515-3 10.1161/01.cir.0000442015.53336.12 10.1172/JCI9259 10.1056/NEJMoa1002358 10.1016/j.atherosclerosis.2006.03.007 10.1042/CS20150027 10.1073/pnas.96.12.6920 10.1172/JCI118854 10.1093/ejcts/ezu366 10.1056/NEJMoa0706628 10.1016/j.cardiores.2006.09.021 10.1016/0092-8674(92)90362-G 10.1016/S0021-9258(18)82232-3 10.12998/wjcc.v2.i5.126 10.1371/journal.pone.0007037 10.1016/j.ahj.2011.06.012 10.1172/JCI42946 10.1172/JCI26130 10.1161/CIR.0b013e3182009701 10.1073/pnas.89.10.4471 10.1016/S0140-6736(08)60763-1 10.1016/j.molmed.2013.12.001 10.1161/01.CIR.0000158435.98035.8D 10.1056/NEJMoa1410489 10.1038/nm.3258 10.1016/j.ijcard.2013.07.113 10.1001/jama.2009.954 10.1161/01.ATV.0000128849.12617.f4 10.1097/MOL.0b013e32833ded6a 10.1038/nature11260 10.1056/NEJM198807073190105 10.1097/MOL.0b013e3283646e4d 10.1038/nm.2538 10.1160/TH13-08-0699 10.1016/0014-5793(76)80996-9 10.1161/01.ATV.15.5.551 10.1161/ATVBAHA.108.176644 10.1161/ATVBAHA.111.236158 10.1146/annurev.immunol.021908.132620 10.1056/NEJMoa1206797 10.2174/13816128113199990365 10.1093/eurheartj/eht296 10.1172/JCI117117 10.1001/jama.2014.11061 10.1172/JCI116663 10.3389/fphys.2014.00291 10.1161/CIRCULATIONAHA.115.018381 10.1056/NEJMoa1315878 10.1172/JCI24061 10.1073/pnas.92.18.8264 10.1161/HYPERTENSIONAHA.107.089854 10.4049/jimmunol.173.10.6403 10.1016/j.ejphar.2006.03.078 10.1152/physiolgenomics.00051.2006 10.1073/pnas.1222878110 10.1093/eurheartj/ehv174 10.1016/j.jacc.2007.11.075 10.1007/s10103-007-0535-x 10.1182/blood-2009-07-235028 10.1056/NEJM200507073530117 10.2353/ajpath.2007.061196 10.1056/NEJMoa0807646 10.1161/01.ATV.20.12.2593 10.1093/eurheartj/ehs092 10.1161/STROKEAHA.113.004229 10.2174/1381612054865064 10.1093/cvr/cvm093 10.1007/s11883-012-0295-3 10.1371/journal.pone.0141019 10.1161/ATVBAHA.107.142570 10.1038/nm810 10.1007/s11883-011-0219-7 10.1016/j.jbiomech.2014.01.011 10.1073/pnas.86.4.1372 10.1038/ng1161 10.1177/1708538113478758 10.1016/j.ahj.2013.03.018 10.2174/1381612822666151109111511 10.1016/j.jacc.2014.01.015 10.1093/eurheartj/ehu041 10.1038/nrd1112 |
ContentType | Journal Article |
Copyright | Elsevier Ireland Ltd 2016 Elsevier Ireland Ltd Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: Elsevier Ireland Ltd – notice: 2016 Elsevier Ireland Ltd – notice: Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.atherosclerosis.2016.03.013 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1484 |
EndPage | 116 |
ExternalDocumentID | 10_1016_j_atherosclerosis_2016_03_013 26999293 S0021915016300880 1_s2_0_S0021915016300880 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AEXQZ AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A NCXOZ O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM 0SF AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c444t-2a820de7c6600a922b47273914125afc2bfd05bf0ac285f0dc45d8f94aaaf9af3 |
IEDL.DBID | AIKHN |
ISSN | 0021-9150 |
IngestDate | Fri Oct 25 05:14:20 EDT 2024 Thu Sep 26 18:21:27 EDT 2024 Sat Sep 28 08:06:31 EDT 2024 Fri Feb 23 02:24:04 EST 2024 Tue Oct 15 14:34:04 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Clinical trials Therapy Research Personalized medicine Coronary artery disease Atherosclerosis |
Language | English |
License | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c444t-2a820de7c6600a922b47273914125afc2bfd05bf0ac285f0dc45d8f94aaaf9af3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
PMID | 26999293 |
PQID | 1782216430 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1782216430 crossref_primary_10_1016_j_atherosclerosis_2016_03_013 pubmed_primary_26999293 elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2016_03_013 elsevier_clinicalkeyesjournals_1_s2_0_S0021915016300880 |
PublicationCentury | 2000 |
PublicationDate | 2016-05-01 |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Caligiuri, Levy, Pernow, Thoren, Hansson (bib62) 1999; 96 Schwartz, Olsson, Abt, Ballantyne, Barter, Brumm, Chaitman, Holme, Kallend, Leiter, Leitersdorf, McMurray, Mundl, Nicholls, Shah, Tardif, Wright (bib77) 2012; 367 Mintz (bib82) 2014; 64 Tobert (bib30) 2003; 2 Babaev, Gleaves, Carter, Suzuki, Kodama, Fazio, Linton (bib50) 2000; 20 Kolh, Windecker, Alfonso, Collet, Cremer, Falk, Filippatos, Hamm, Head, Jüni, Kappetein, Kastrati, Knuuti, Landmesser, Laufer, Neumann, Richter, Schauerte, Sousa Uva, Stefanini, Taggart, Torracca, Valgimigli, Wijns, Witkowski, Zamorano, Achenbach, Baumgartner, Bax, Bueno, Dean, Deaton, Erol, Fagard, Ferrari, Hasdai, Hoes, Kirchhof, Knuuti, Kolh, Lancellotti, Linhart, Nihoyannopoulos, Piepoli, Ponikowski, Sirnes, Tamargo, Tendera, Torbicki, Wijns, Windecker, Sousa Uva, Achenbach, Pepper, Anyanwu, Badimon, Bauersachs, Baumbach, Beygui, Bonaros, De Carlo, Deaton, Dobrev, Dunning, Eeckhout, Gielen, Hasdai, Kirchhof, Luckraz, Mahrholdt, Montalescot, Paparella, Rastan, Sanmartin, Sergeant, Silber, Tamargo, ten Berg, Thiele, van Geuns, Wagner, Wassmann, Wendler, Zamorano (bib56) 2014; 46 Tardif, McMurray, Klug, Small, Schumi, Choi, Cooper, Scott, Lewis, L'Allier, Pfeffer, I. Aggressive Reduction of Inflammation Stops Events Trial (bib74) 2008; 371 Korosoglou, Giusca, Gitsioudis, Erbel, Katus (bib81) 2014; 5 Moore, Kunjathoor, Koehn, Manning, Tseng, Silver, McKee, Freeman (bib53) 2005; 115 Robbins, Hilgendorf, Weber, Theurl, Iwamoto, Figueiredo, Gorbatov, Sukhova, Gerhardt, Smyth, Zavitz, Shikatani, Parsons, van Rooijen, Lin, Husain, Libby, Nahrendorf, Weissleder, Swirski (bib46) 2013; 19 Zadelaar, Kleemann, Verschuren, de Vries-Van der Weij, van der Hoorn, Princen, Kooistra (bib39) 2007; 27 Bentzon, Falk (bib60) 2010; 21 Galkina, Ley (bib6) 2009; 27 Holzapfel, Mulvihill, Cunnane, Walsh (bib80) 2014; 47 Ridker (bib4) 2013; 15 Smith, Trogan, Ginsberg, Grigaux, Tian, Miyata (bib43) 1995; 92 Dutta, Courties, Wei, Leuschner, Gorbatov, Robbins, Iwamoto, Thompson, Carlson, Heidt, Majmudar, Lasitschka, Etzrodt, Waterman, Waring, Chicoine, van der Laan, Niessen, Piek, Rubin, Butany, Stone, Katus, Murphy, Morrow, Sabatine, Vinegoni, Moskowitz, Pittet, Libby, Lin, Swirski, Weissleder, Nahrendorf (bib63) 2012; 487 Bohula, Giugliano, Cannon, Zhou, Murphy, White, Tershakovec, Blazing, Braunwald (bib13) 2015; 132 van den Maagdenberg, Hofker, Krimpenfort, de Bruijn, van Vlijmen, van der Boom, Havekes, Frants (bib58) 1993; 268 Stone, Maehara, Lansky, de Bruyne, Cristea, Mintz, Mehran, McPherson, Farhat, Marso, Parise, Templin, White, Zhang, Serruys (bib20) 2011; 364 Koenig (bib79) 2013; 168 Plump, Smith, Hayek, Aalto-Setala, Walsh, Verstuyft, Rubin, Breslow (bib36) 1992; 71 Johnson, Carson, Williams, Karanam, Newby, Angelini, George, Jackson (bib68) 2005; 111 Perk, De Backer, Gohlke, Graham, Reiner, Verschuren, Albus, Benlian, Boysen, Cifkova, Deaton, Ebrahim, Fisher, Germano, Hobbs, Hoes, Karadeniz, Mezzani, Prescott, Ryden, Scherer, Syvanne, Scholte op Reimer, Vrints, Wood, Zamorano, Zannad, P. European Association for Cardiovascular, Rehabilitation and E. S. C. C. f. P. Guidelines (bib26) 2012; 33 Agouridis, Elisaf, Nair, Mikhailidis (bib27) 2015; 22 Ingersoll, Spanbroek, Lottaz, Gautier, Frankenberger, Hoffmann, Lang, Haniffa, Collin, Tacke, Habenicht, Ziegler-Heitbrock, Randolph (bib65) 2010; 115 Kapourchali, Surendiran, Chen, Uitz, Bahadori, Moghadasian (bib40) 2014; 2 Witztum (bib55) 2005; 115 Erbel, Rupp, Helmes, Tyka, Linden, Doesch, Katus, Gleissner (bib71) 2013; 76 Barter, Caulfield, Eriksson, Grundy, Kastelein, Komajda, Lopez-Sendon, Mosca, Tardif, Waters, Shear, Revkin, Buhr, Fisher, Tall, Brewer (bib76) 2007; 357 O'Donoghue, Braunwald, White (bib16) 2014; 312 Febbraio, Podrez, Smith, Hajjar, Hazen, Hoff, Sharma, Silverstein (bib51) 2000; 105 Everett, Pradhan, Solomon, Paynter, MacFadyen, Zaharris, Gupta, Clearfield, Libby, Hasan, Glynn, Ridker (bib18) 2013; 166 Stone, Maehara, Lansky, de Bruyne, Cristea, Mintz, Mehran, McPherson, Farhat, Marso, Parise, Templin, White, Zhang, Serruys, Investigators (bib61) 2011; 364 Shashkin, Dragulev, Ley (bib23) 2005; 11 Van der Donckt, Van Herck, Schrijvers, Vanhoutte, Verhoye, Blockx, Van Der Linden, Bauters, Lijnen, Sluimer, Roth, Van Hove, Fransen, Knaapen, Hervent, De Keulenaer, Bult, Martinet, Herman, De Meyer (bib47) 2015 May 1; 36 Johnson, Jackson (bib67) 2001; 154 Cannon, Blazing, Giugliano, McCagg, White, Theroux, Darius, Lewis, Ophuis, Jukema, De Ferrari, Ruzyllo, De Lucca, Im, Bohula, Reist, Wiviott, Tershakovec, Musliner, Braunwald, Califf, Investigators (bib32) 2015; 372 Millon, Canet-Soulas, Boussel, Fayad, Douek (bib41) 2014 Jun; 22 Satoh, Takahashi, Tabuchi, Minami, Tamada, Takahashi, Itoh, Morino, Nakamura (bib31) 2015; 129 Virchow (bib7) 1856; 51 Kuchibhotla, Vanegas, Kennedy, Guy, Nimako, Morton, Febbraio (bib52) 2008; 78 Shimada, Cannon (bib33) 2015; 36 Palinski, Rosenfeld, Yla-Herttuala, Gurtner, Socher, Butler, Parthasarathy, Carew, Steinberg, Witztum (bib10) 1989; 86 Abifadel, Varret, Rabes, Allard, Ouguerram, Devillers, Cruaud, Benjannet, Wickham, Erlich, Derre, Villeger, Farnier, Beucler, Bruckert, Chambaz, Chanu, Lecerf, Luc, Moulin, Weissenbach, Prat, Krempf, Junien, Seidah, Boileau (bib34) 2003; 34 Gleissner, Leitinger, Ley (bib22) 2007; 50 Huo, Schober, Forlow, Smith, Hyman, Jung, Littman, Weber, Ley (bib45) 2003; 9 Muller, Katus, Bekeredjian (bib87) 2007; 73 Nadkarni, Bouma, de Boer, Tearney (bib83) 2009; 24 J.-C. Tardif, J. J. V. McMurray, E. Klug, R. Small, J. Schumi, J. Choi, J. Cooper, R. Scott, E. F. Lewis, P. L. L'Allier and M. A. Pfeffer: Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet, 371(9626), 1761–1768. Grundy (bib29) 1988; 319 Weber, Noels (bib49) 2011; 17 Elliott, Chambers, Zhang (bib17) 2009; 302 Hartwig, Silvestre-Roig, Hendrikse, Beckers, Paulin, Van der Heiden, Braster, Drechsler, Daemen, Lutgens, Soehnlein (bib70) 2015; 10 Schenkel, Chew, Muller (bib64) 2004; 173 Seok, Warren, Cuenca, Mindrinos, Baker, Xu, Richards, McDonald-Smith, Gao, Hennessy, Finnerty, López, Honari, Moore, Minei, Cuschieri, Bankey, Johnson, Sperry, Nathens, Billiar, West, Jeschke, Klein, Gamelli, Gibran, Brownstein, Miller-Graziano, Calvano, Mason, Cobb, Rahme, Lowry, Maier, Moldawer, Herndon, Davis, Xiao, Tompkins (bib66) 2013 Feb 26; 110 Manning-Tobin, Moore, Seimon, Bell, Sharuk, Alvarez-Leite, de Winther, Tabas, Freeman (bib54) 2008; 29 Terasaka, Miyazaki, Kasanuki, Ito, Ubukata, Koieyama, Kitayama, Tanimoto, Maeda, Inaba (bib73) 2007; 190 Pitt, Loscalzo, Ycas, Raichlen (bib59) 2008; 51 Ridker, Danielson, Fonseca, Genest, Gotto, Kastelein, Koenig, Libby, Lorenzatti, MacFadyen, Nordestgaard, Shepherd, Willerson, Glynn (bib12) 2008; 359 Hartwig, Drechsler, Lievens, Kramp, von Hundelshausen, Lutgens, Weber, Doring, Soehnlein (bib48) 2014; 111 Jin, Shen, Nie, Yuan, Hu, Li, Chen, Zhang, He (bib69) 2012; 32 Puri, Nissen (bib84) 2013; 19 Sinnaeve, Donahue, Grass, Seo, Vonderscher, Chibout, Kraus, Sketch, Nelson, Ginsburg, Goldschmidt-Clermont, Granger (bib85) 2009; 4 Schiener, Hossann, Viola, Ortega-Gomez, Weber, Lauber, Lindner, Soehnlein (bib88) 2014; 20 Cho, Shashkin, Gleissner, Dunson, Jain, Lee, Miller, Ley (bib24) 2007; 29 Volger, Fledderus, Kisters, Fontijn, Moerland, Kuiper, van Berkel, Bijnens, Daemen, Pannekoek, Horrevoets (bib86) 2007; 171 Gerrity (bib8) 1981; 103 Williams, Tabas (bib11) 1995; 15 Ishibashi, Brown, Goldstein, Gerard, Hammer, Herz (bib37) 1993; 92 Cannon, Murphy, Braunwald (bib21) 2005; 353 van Vlijmen, van den Maagdenberg, Gijbels, van der Boom, HogenEsch, Frants, Hofker, Havekes (bib57) 1994; 93 Erbel, Okuyucu, Akhavanpoor, Zhao, Wangler, Hakimi, Doesch, Dengler, Katus, Gleissner (bib72) 2014; 87 Ridker, Thuren, Zalewski, Libby (bib19) 2011; 162 Besler, Heinrich, Rohrer, Doerries, Riwanto, Shih, Chroni, Yonekawa, Stein, Schaefer, Mueller, Akhmedov, Daniil, Manes, Templin, Wyss, Maier, Tanner, Matter, Corti, Furlong, Lusis, von Eckardstein, Fogelman, Luscher, Landmesser (bib78) 2011; 121 Go, Mozaffarian, Roger, Benjamin, Berry, Blaha, Dai, Ford, Fox, Franco, Fullerton, Gillespie, Hailpern, Heit, Howard, Huffman, Judd, Kissela, Kittner, Lackland, Lichtman, Lisabeth, Mackey, Magid, Marcus, Marelli, Matchar, McGuire, Mohler, Moy, Mussolino, Neumar, Nichol, Pandey, Paynter, Reeves, Sorlie, Stein, Towfighi, Turan, Virani, Wong, Woo, Turner (bib1) 2014; 129 Sampson, Fazio, Linton (bib3) 2012; 14 Endo, Kuroda, Tanzawa (bib28) 1976; 72 Piedrahita, Zhang, Hagaman, Oliver, Maeda (bib35) 1992; 89 Sirimarco, Labreuche, Bruckert, Goldstein, Fox, Rothwell, Amarenco, Perform, S. Investigators and Committees (bib5) 2014; 45 Gerrity (bib9) 1981; 103 (bib15) 2014; 370 Task Force, Montalescot, Sechtem, Achenbach, Andreotti, Arden, Budaj, Bugiardini, Crea, Cuisset, Di Mario, Ferreira, Gersh, Gitt, Hulot, Marx, Opie, Pfisterer, Prescott, Ruschitzka, Sabate, Senior, Taggart, van der Wall, Vrints, E. S. C. C. f. P. Guidelines, Zamorano, Achenbach, Baumgartner, Bax, Bueno, Dean, Deaton, Erol, Fagard, Ferrari, Hasdai, Hoes, Kirchhof, Knuuti, Kolh, Lancellotti, Linhart, Nihoyannopoulos, Piepoli, Ponikowski, Sirnes, Tamargo, Tendera, Torbicki, Wijns, Windecker, Document, Knuuti, Valgimigli, Bueno, Claeys, Donner-Banzhoff, Erol, Frank, Funck-Brentano, Gaemperli, Gonzalez-Juanatey, Hamilos, Hasdai, Husted, James, Kervinen, Kolh, Kristensen, Lancellotti, Maggioni, Piepoli, Pries, Romeo, Ryden, Simoons, Sirnes, Steg, Timmis, Wijns, Windecker, Yildirir, Zamorano (bib25) 2013; 34 Kitayama, Koga, Maeda, Inaba, Fujioka (bib75) 2006; 539 Meir, Leitersdorf (bib38) 2004; 24 Roger, Go, Lloyd-Jones, Adams, Berry, Brown, Carnethon, Dai, de Simone, Ford, Fox, Fullerton, Gillespie, Greenlund, Hailpern, Heit, Ho, Howard, Kissela, Kittner, Lackland, Lichtman, Lisabeth, Makuc, Marcus, Marelli, Matchar, McDermott, Meigs, Moy, Mozaffarian, Mussolino, Nichol, Paynter, Rosamond, Sorlie, Stafford, Turan, Turner, Wong, Wylie-Rosett, o. b. o. t. A. H. A. S. Commi Matoba (10.1016/j.atherosclerosis.2016.03.013_bib42) 2013; 24 van Vlijmen (10.1016/j.atherosclerosis.2016.03.013_bib57) 1994; 93 Puri (10.1016/j.atherosclerosis.2016.03.013_bib84) 2013; 19 Mintz (10.1016/j.atherosclerosis.2016.03.013_bib82) 2014; 64 Task Force (10.1016/j.atherosclerosis.2016.03.013_bib25) 2013; 34 Witztum (10.1016/j.atherosclerosis.2016.03.013_bib55) 2005; 115 Cannon (10.1016/j.atherosclerosis.2016.03.013_bib21) 2005; 353 Smith (10.1016/j.atherosclerosis.2016.03.013_bib43) 1995; 92 Ridker (10.1016/j.atherosclerosis.2016.03.013_bib12) 2008; 359 Sinnaeve (10.1016/j.atherosclerosis.2016.03.013_bib85) 2009; 4 Van der Donckt (10.1016/j.atherosclerosis.2016.03.013_bib47) 2015; 36 Gerrity (10.1016/j.atherosclerosis.2016.03.013_bib8) 1981; 103 Stone (10.1016/j.atherosclerosis.2016.03.013_bib61) 2011; 364 Kolh (10.1016/j.atherosclerosis.2016.03.013_bib56) 2014; 46 Caligiuri (10.1016/j.atherosclerosis.2016.03.013_bib62) 1999; 96 van den Maagdenberg (10.1016/j.atherosclerosis.2016.03.013_bib58) 1993; 268 Galkina (10.1016/j.atherosclerosis.2016.03.013_bib6) 2009; 27 Cho (10.1016/j.atherosclerosis.2016.03.013_bib24) 2007; 29 Volger (10.1016/j.atherosclerosis.2016.03.013_bib86) 2007; 171 Roger (10.1016/j.atherosclerosis.2016.03.013_bib2) 2011; 123 Manning-Tobin (10.1016/j.atherosclerosis.2016.03.013_bib54) 2008; 29 Moore (10.1016/j.atherosclerosis.2016.03.013_bib53) 2005; 115 Ridker (10.1016/j.atherosclerosis.2016.03.013_bib19) 2011; 162 Muller (10.1016/j.atherosclerosis.2016.03.013_bib87) 2007; 73 10.1016/j.atherosclerosis.2016.03.013_bib14 Schiener (10.1016/j.atherosclerosis.2016.03.013_bib88) 2014; 20 Bentzon (10.1016/j.atherosclerosis.2016.03.013_bib60) 2010; 21 Grundy (10.1016/j.atherosclerosis.2016.03.013_bib29) 1988; 319 Seok (10.1016/j.atherosclerosis.2016.03.013_bib66) 2013; 110 Kapourchali (10.1016/j.atherosclerosis.2016.03.013_bib40) 2014; 2 Sampson (10.1016/j.atherosclerosis.2016.03.013_bib3) 2012; 14 Kitayama (10.1016/j.atherosclerosis.2016.03.013_bib75) 2006; 539 Satoh (10.1016/j.atherosclerosis.2016.03.013_bib31) 2015; 129 Kuchibhotla (10.1016/j.atherosclerosis.2016.03.013_bib52) 2008; 78 Erbel (10.1016/j.atherosclerosis.2016.03.013_bib72) 2014; 87 Tardif (10.1016/j.atherosclerosis.2016.03.013_bib74) 2008; 371 Febbraio (10.1016/j.atherosclerosis.2016.03.013_bib51) 2000; 105 Everett (10.1016/j.atherosclerosis.2016.03.013_bib18) 2013; 166 Elliott (10.1016/j.atherosclerosis.2016.03.013_bib17) 2009; 302 Dutta (10.1016/j.atherosclerosis.2016.03.013_bib63) 2012; 487 Gerrity (10.1016/j.atherosclerosis.2016.03.013_bib9) 1981; 103 Babaev (10.1016/j.atherosclerosis.2016.03.013_bib50) 2000; 20 Ingersoll (10.1016/j.atherosclerosis.2016.03.013_bib65) 2010; 115 Ishibashi (10.1016/j.atherosclerosis.2016.03.013_bib37) 1993; 92 Huo (10.1016/j.atherosclerosis.2016.03.013_bib45) 2003; 9 Bohula (10.1016/j.atherosclerosis.2016.03.013_bib13) 2015; 132 Erbel (10.1016/j.atherosclerosis.2016.03.013_bib71) 2013; 76 Sirimarco (10.1016/j.atherosclerosis.2016.03.013_bib5) 2014; 45 Jin (10.1016/j.atherosclerosis.2016.03.013_bib69) 2012; 32 Besler (10.1016/j.atherosclerosis.2016.03.013_bib78) 2011; 121 Virchow (10.1016/j.atherosclerosis.2016.03.013_bib7) 1856; 51 Piedrahita (10.1016/j.atherosclerosis.2016.03.013_bib35) 1992; 89 Abifadel (10.1016/j.atherosclerosis.2016.03.013_bib34) 2003; 34 Johnson (10.1016/j.atherosclerosis.2016.03.013_bib67) 2001; 154 Endo (10.1016/j.atherosclerosis.2016.03.013_bib28) 1976; 72 Koenig (10.1016/j.atherosclerosis.2016.03.013_bib79) 2013; 168 Ridker (10.1016/j.atherosclerosis.2016.03.013_bib4) 2013; 15 Shimada (10.1016/j.atherosclerosis.2016.03.013_bib33) 2015; 36 Robbins (10.1016/j.atherosclerosis.2016.03.013_bib46) 2013; 19 Terasaka (10.1016/j.atherosclerosis.2016.03.013_bib73) 2007; 190 Zadelaar (10.1016/j.atherosclerosis.2016.03.013_bib39) 2007; 27 Horkko (10.1016/j.atherosclerosis.2016.03.013_bib44) 1996; 98 Hartwig (10.1016/j.atherosclerosis.2016.03.013_bib70) 2015; 10 Gleissner (10.1016/j.atherosclerosis.2016.03.013_bib22) 2007; 50 Agouridis (10.1016/j.atherosclerosis.2016.03.013_bib27) 2015; 22 Tobert (10.1016/j.atherosclerosis.2016.03.013_bib30) 2003; 2 O'Donoghue (10.1016/j.atherosclerosis.2016.03.013_bib16) 2014; 312 Millon (10.1016/j.atherosclerosis.2016.03.013_bib41) 2014; 22 Plump (10.1016/j.atherosclerosis.2016.03.013_bib36) 1992; 71 Weber (10.1016/j.atherosclerosis.2016.03.013_bib49) 2011; 17 Cannon (10.1016/j.atherosclerosis.2016.03.013_bib32) 2015; 372 Johnson (10.1016/j.atherosclerosis.2016.03.013_bib68) 2005; 111 Williams (10.1016/j.atherosclerosis.2016.03.013_bib11) 1995; 15 Pitt (10.1016/j.atherosclerosis.2016.03.013_bib59) 2008; 51 (10.1016/j.atherosclerosis.2016.03.013_bib15) 2014; 370 Schenkel (10.1016/j.atherosclerosis.2016.03.013_bib64) 2004; 173 Barter (10.1016/j.atherosclerosis.2016.03.013_bib76) 2007; 357 Go (10.1016/j.atherosclerosis.2016.03.013_bib1) 2014; 129 Stone (10.1016/j.atherosclerosis.2016.03.013_bib20) 2011; 364 Korosoglou (10.1016/j.atherosclerosis.2016.03.013_bib81) 2014; 5 Shashkin (10.1016/j.atherosclerosis.2016.03.013_bib23) 2005; 11 Nadkarni (10.1016/j.atherosclerosis.2016.03.013_bib83) 2009; 24 Palinski (10.1016/j.atherosclerosis.2016.03.013_bib10) 1989; 86 Holzapfel (10.1016/j.atherosclerosis.2016.03.013_bib80) 2014; 47 Perk (10.1016/j.atherosclerosis.2016.03.013_bib26) 2012; 33 Hartwig (10.1016/j.atherosclerosis.2016.03.013_bib48) 2014; 111 Meir (10.1016/j.atherosclerosis.2016.03.013_bib38) 2004; 24 Schwartz (10.1016/j.atherosclerosis.2016.03.013_bib77) 2012; 367 |
References_xml | – volume: 4 start-page: e7037 year: 2009 ident: bib85 article-title: Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease publication-title: PLoS One contributor: fullname: Granger – volume: 45 start-page: 1429 year: 2014 end-page: 1436 ident: bib5 article-title: Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients publication-title: Stroke contributor: fullname: Perform, S. Investigators and Committees – volume: 115 year: 2010 ident: bib65 article-title: Comparison of gene expression profiles between human and mouse monocyte subsets publication-title: Blood contributor: fullname: Randolph – volume: 132 start-page: 1224 year: 2015 end-page: 1233 ident: bib13 article-title: Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of Ezetimibe to Simvastatin and associated with better outcomes in IMPROVE-IT publication-title: Circulation contributor: fullname: Braunwald – volume: 123 start-page: e18 year: 2011 end-page: 209 ident: bib2 article-title: Disease and stroke statistics writing group: heart disease and stroke statistics–2011 update: a report from the American heart association publication-title: Circulation contributor: fullname: o. b. o. t. A. H. A. S. Committee, Stroke Statistics Subcommittee, O. b. o. t. A. H. A. H – volume: 92 start-page: 883 year: 1993 end-page: 893 ident: bib37 article-title: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery publication-title: J. Clin. Invest. contributor: fullname: Herz – volume: 86 start-page: 1372 year: 1989 end-page: 1376 ident: bib10 article-title: Low density lipoprotein undergoes oxidative modification in vivo publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Witztum – volume: 27 start-page: 1706 year: 2007 end-page: 1721 ident: bib39 article-title: Mouse models for atherosclerosis and pharmaceutical modifiers publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: Kooistra – volume: 19 start-page: 5963 year: 2013 end-page: 5971 ident: bib84 article-title: The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development publication-title: Curr. Pharm. Des. contributor: fullname: Nissen – volume: 302 start-page: 37 year: 2009 end-page: 48 ident: bib17 article-title: GEnetic loci associated with c-reactive protein levels and risk of coronary heart disease publication-title: JAMA contributor: fullname: Zhang – volume: 34 start-page: 2949 year: 2013 end-page: 3003 ident: bib25 article-title: 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology publication-title: Eur. Heart J. contributor: fullname: Zamorano – volume: 14 start-page: 1 year: 2012 end-page: 10 ident: bib3 article-title: Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges publication-title: Curr. Atheroscler. Rep. contributor: fullname: Linton – volume: 89 start-page: 4471 year: 1992 end-page: 4475 ident: bib35 article-title: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Maeda – volume: 22 start-page: 221 year: 2014 Jun end-page: 237 ident: bib41 article-title: Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression publication-title: Vascular contributor: fullname: Douek – volume: 364 start-page: 226 year: 2011 end-page: 235 ident: bib61 article-title: A prospective natural-history study of coronary atherosclerosis publication-title: N. Engl. J. Med. contributor: fullname: Investigators – volume: 353 start-page: 93 year: 2005 end-page: 96 ident: bib21 article-title: Intensive lipid lowering with atorvastatin in coronary disease publication-title: N. Engl. J. Med. contributor: fullname: Braunwald – volume: 11 start-page: 3061 year: 2005 end-page: 3072 ident: bib23 article-title: Macrophage differentiation to foam cells publication-title: Curr. Pharm. Des. contributor: fullname: Ley – volume: 371 start-page: 1761 year: 2008 end-page: 1768 ident: bib74 article-title: Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial publication-title: Lancet contributor: fullname: I. Aggressive Reduction of Inflammation Stops Events Trial – volume: 367 start-page: 2089 year: 2012 end-page: 2099 ident: bib77 article-title: Effects of dalcetrapib in patients with a recent acute coronary syndrome publication-title: N. Engl. J. Med. contributor: fullname: Wright – volume: 129 start-page: 399 year: 2014 end-page: 410 ident: bib1 article-title: Executive summary: heart disease and stroke statistics—2014 update: a report from the American heart association publication-title: Circulation contributor: fullname: Turner – volume: 10 start-page: e0141019 year: 2015 ident: bib70 article-title: Atherosclerotic plaque destabilization in mice: a comparative study publication-title: PLoS One contributor: fullname: Soehnlein – volume: 32 start-page: 2372 year: 2012 end-page: 2379 ident: bib69 article-title: Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: He – volume: 312 start-page: 1006 year: 2014 end-page: 1015 ident: bib16 article-title: Effect of darapladib on major coronary events after an acute coronary syndrome: the solid-timi 52 randomized clinical trial publication-title: JAMA contributor: fullname: White – volume: 93 start-page: 1403 year: 1994 end-page: 1410 ident: bib57 article-title: Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice publication-title: J. Clin. Invest contributor: fullname: Havekes – volume: 15 start-page: 295 year: 2013 ident: bib4 article-title: Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? publication-title: Curr. Atheroscler. Rep. contributor: fullname: Ridker – volume: 166 year: 2013 ident: bib18 article-title: Rationale and design of the cardiovascular inflammation reduction trial (CIRT): A test of the inflammatory hypothesis of atherothrombosis publication-title: Am. heart J. contributor: fullname: Ridker – volume: 2 start-page: 126 year: 2014 end-page: 132 ident: bib40 article-title: Animal models of atherosclerosis publication-title: World J. Clin. Cases contributor: fullname: Moghadasian – volume: 154 start-page: 399 year: 2001 end-page: 406 ident: bib67 article-title: Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse publication-title: Atherosclerosis contributor: fullname: Jackson – volume: 34 start-page: 154 year: 2003 end-page: 156 ident: bib34 article-title: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia publication-title: Nat. Genet. contributor: fullname: Boileau – volume: 33 start-page: 1635 year: 2012 end-page: 1701 ident: bib26 article-title: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) publication-title: Eur. Heart J. contributor: fullname: P. European Association for Cardiovascular, Rehabilitation and E. S. C. C. f. P. Guidelines – volume: 72 start-page: 323 year: 1976 end-page: 326 ident: bib28 article-title: Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity publication-title: FEBS Lett. contributor: fullname: Tanzawa – volume: 36 start-page: 1049 year: 2015 May 1 end-page: 1058 ident: bib47 article-title: Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death publication-title: Eur. Heart J. contributor: fullname: De Meyer – volume: 46 start-page: 517 year: 2014 end-page: 592 ident: bib56 article-title: 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI) publication-title: Eur. J. Cardio-Thoracic Surg. contributor: fullname: Zamorano – volume: 92 start-page: 8264 year: 1995 end-page: 8268 ident: bib43 article-title: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Miyata – volume: 20 start-page: 271 year: 2014 end-page: 281 ident: bib88 article-title: Nanomedicine-based strategies for treatment of atherosclerosis publication-title: Trends Mol. Med. contributor: fullname: Soehnlein – volume: 9 start-page: 61 year: 2003 end-page: 67 ident: bib45 article-title: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E publication-title: Nat. Med. contributor: fullname: Ley – volume: 171 start-page: 326 year: 2007 end-page: 337 ident: bib86 article-title: Distinctive expression of chemokines and transforming growth factor-β Signaling in human arterial endothelium during atherosclerosis publication-title: Am. J. Pathol. contributor: fullname: Horrevoets – volume: 487 start-page: 325 year: 2012 end-page: 329 ident: bib63 article-title: Myocardial infarction accelerates atherosclerosis publication-title: Nature contributor: fullname: Nahrendorf – volume: 115 start-page: 2192 year: 2005 end-page: 2201 ident: bib53 article-title: Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice publication-title: J. Clin. Invest. contributor: fullname: Freeman – volume: 87 year: 2014 ident: bib72 article-title: A human ex vivo atherosclerotic plaque model to study lesion biology publication-title: J. Vis. Exp. contributor: fullname: Gleissner – volume: 115 start-page: 2072 year: 2005 end-page: 2075 ident: bib55 article-title: You are right too! publication-title: J. Clin. Invest. contributor: fullname: Witztum – volume: 27 start-page: 165 year: 2009 end-page: 197 ident: bib6 article-title: Immune and inflammatory mechanisms of atherosclerosis (*) publication-title: Annu. Rev. Immunol. contributor: fullname: Ley – volume: 121 start-page: 2693 year: 2011 end-page: 2708 ident: bib78 article-title: Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease publication-title: J. Clin. Invest contributor: fullname: Landmesser – volume: 51 start-page: 1440 year: 2008 end-page: 1445 ident: bib59 article-title: Lipid levels after acute coronary syndromes publication-title: J. Am. Coll. Cardiol. contributor: fullname: Raichlen – volume: 17 start-page: 1410 year: 2011 end-page: 1422 ident: bib49 article-title: Atherosclerosis: current pathogenesis and therapeutic options publication-title: Nat. Med. contributor: fullname: Noels – volume: 76 start-page: e50332 year: 2013 ident: bib71 article-title: An in vitro model to study heterogeneity of human macrophage differentiation and polarization publication-title: J. Vis. Exp. contributor: fullname: Gleissner – volume: 539 start-page: 81 year: 2006 end-page: 88 ident: bib75 article-title: Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits publication-title: Eur. J. Pharmacol. contributor: fullname: Fujioka – volume: 47 start-page: 859 year: 2014 end-page: 869 ident: bib80 article-title: Computational approaches for analyzing the mechanics of atherosclerotic plaques: a review publication-title: J. Biomech. contributor: fullname: Walsh – volume: 110 start-page: 3507 year: 2013 Feb 26 end-page: 3512 ident: bib66 article-title: Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases publication-title: Proc. Natl. Acad. Sci. U S A. contributor: fullname: Tompkins – volume: 111 start-page: 1422 year: 2005 end-page: 1430 ident: bib68 article-title: Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment publication-title: Circulation contributor: fullname: Jackson – volume: 103 start-page: 181 year: 1981 end-page: 190 ident: bib9 article-title: The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions publication-title: Am. J. Pathol. contributor: fullname: Gerrity – volume: 73 start-page: 453 year: 2007 end-page: 462 ident: bib87 article-title: Targeting the heart with gene therapy-optimized gene delivery methods publication-title: Cardiovasc. Res. contributor: fullname: Bekeredjian – volume: 162 start-page: 597 year: 2011 end-page: 605 ident: bib19 article-title: Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) publication-title: Am. Heart J. contributor: fullname: Libby – volume: 29 start-page: 149 year: 2007 end-page: 160 ident: bib24 article-title: Induction of dendritic cell-like phenotype in macrophages during foam cell formation publication-title: Physiol. Genom. contributor: fullname: Ley – volume: 173 start-page: 6403 year: 2004 end-page: 6408 ident: bib64 article-title: Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains publication-title: J. Immunol. contributor: fullname: Muller – volume: 357 start-page: 2109 year: 2007 end-page: 2122 ident: bib76 article-title: Effects of torcetrapib in patients at high risk for coronary events publication-title: N. Engl. J. Med. contributor: fullname: Brewer – volume: 129 start-page: 93 year: 2015 end-page: 105 ident: bib31 article-title: Cellular and molecular mechanisms of statins: an update on pleiotropic effects publication-title: Clin. Sci. (Lond) contributor: fullname: Nakamura – volume: 15 start-page: 551 year: 1995 end-page: 561 ident: bib11 article-title: The response-to-retention hypothesis of early atherogenesis publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: Tabas – volume: 98 start-page: 815 year: 1996 end-page: 825 ident: bib44 article-title: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein publication-title: J. Clin. Invest. contributor: fullname: Witztum – volume: 5 start-page: 291 year: 2014 ident: bib81 article-title: Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification publication-title: Front. Physiol. contributor: fullname: Katus – volume: 103 start-page: 191 year: 1981 end-page: 200 ident: bib8 article-title: The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions publication-title: Am. J. Pathol. contributor: fullname: Gerrity – volume: 51 start-page: 809 year: 1856 end-page: 812 ident: bib7 article-title: Der atheromatöse Prozess der Arterien publication-title: Wien. Med. Wochenschr contributor: fullname: Virchow – volume: 190 start-page: 239 year: 2007 end-page: 247 ident: bib73 article-title: ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice publication-title: Atherosclerosis contributor: fullname: Inaba – volume: 96 start-page: 6920 year: 1999 end-page: 6924 ident: bib62 article-title: Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Hansson – volume: 319 start-page: 24 year: 1988 end-page: 33 ident: bib29 article-title: HMG-CoA reductase inhibitors for treatment of hypercholesterolemia publication-title: N. Engl. J. Med. contributor: fullname: Grundy – volume: 370 start-page: 1702 year: 2014 end-page: 1711 ident: bib15 article-title: Darapladib for preventing ischemic events in stable coronary heart disease publication-title: N. Engl. J. Med. – volume: 364 start-page: 226 year: 2011 end-page: 235 ident: bib20 article-title: A prospective natural-history study of coronary atherosclerosis publication-title: N. Engl. J. Med. contributor: fullname: Serruys – volume: 22 start-page: 18 year: 2015 end-page: 27 ident: bib27 article-title: All for statins and statins for all; an update publication-title: Curr. Pharm. Des. contributor: fullname: Mikhailidis – volume: 78 start-page: 185 year: 2008 end-page: 196 ident: bib52 article-title: Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II publication-title: Cardiovasc. Res. contributor: fullname: Febbraio – volume: 359 start-page: 2195 year: 2008 end-page: 2207 ident: bib12 article-title: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein publication-title: N. Engl. J. Med. contributor: fullname: Glynn – volume: 36 start-page: 2415 year: 2015 end-page: 2424 ident: bib33 article-title: PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future publication-title: Eur. Heart J. contributor: fullname: Cannon – volume: 50 start-page: 276 year: 2007 end-page: 283 ident: bib22 article-title: Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis publication-title: Hypertension contributor: fullname: Ley – volume: 71 start-page: 343 year: 1992 end-page: 353 ident: bib36 article-title: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells publication-title: Cell contributor: fullname: Breslow – volume: 2 start-page: 517 year: 2003 end-page: 526 ident: bib30 article-title: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors publication-title: Nat. Rev. Drug Discov. contributor: fullname: Tobert – volume: 21 start-page: 434 year: 2010 end-page: 440 ident: bib60 article-title: Atherosclerotic lesions in mouse and man: is it the same disease? publication-title: Curr. Opin. Lipidol. contributor: fullname: Falk – volume: 372 start-page: 2387 year: 2015 end-page: 2397 ident: bib32 article-title: Ezetimibe added to statin therapy after acute coronary syndromes publication-title: N. Engl. J. Med. contributor: fullname: Investigators – volume: 24 start-page: 439 year: 2009 end-page: 445 ident: bib83 article-title: Evaluation of collagen in atherosclerotic plaques: the use of two coherent laser-based imaging methods publication-title: Lasers Med. Sci. contributor: fullname: Tearney – volume: 24 start-page: 419 year: 2013 end-page: 425 ident: bib42 article-title: Mouse models of plaque rupture publication-title: Curr. Opin. Lipidol. contributor: fullname: Egashira – volume: 111 start-page: 562 year: 2014 end-page: 564 ident: bib48 article-title: Platelet-derived PF4 reduces neutrophil apoptosis following arterial occlusion publication-title: Thromb. Haemost. contributor: fullname: Soehnlein – volume: 20 start-page: 2593 year: 2000 end-page: 2599 ident: bib50 article-title: Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: Linton – volume: 105 start-page: 1049 year: 2000 end-page: 1056 ident: bib51 article-title: Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice publication-title: J. Clin. Invest. contributor: fullname: Silverstein – volume: 268 start-page: 10540 year: 1993 end-page: 10545 ident: bib58 article-title: Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia publication-title: J. Biol. Chem. contributor: fullname: Frants – volume: 168 start-page: 5126 year: 2013 end-page: 5134 ident: bib79 article-title: High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy publication-title: Int. J. Cardiol. contributor: fullname: Koenig – volume: 19 start-page: 1166 year: 2013 end-page: 1172 ident: bib46 article-title: Local proliferation dominates lesional macrophage accumulation in atherosclerosis publication-title: Nat. Med. contributor: fullname: Swirski – volume: 64 start-page: 207 year: 2014 end-page: 222 ident: bib82 article-title: Clinical utility of intravascular imaging and physiology in coronary artery disease publication-title: J. Am. Coll. Cardiol. contributor: fullname: Mintz – volume: 24 start-page: 1006 year: 2004 end-page: 1014 ident: bib38 article-title: Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: Leitersdorf – volume: 29 start-page: 19 year: 2008 end-page: 26 ident: bib54 article-title: Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice publication-title: Arterioscler. Thromb. Vasc. Biol. contributor: fullname: Freeman – volume: 154 start-page: 399 issue: 2 year: 2001 ident: 10.1016/j.atherosclerosis.2016.03.013_bib67 article-title: Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse publication-title: Atherosclerosis doi: 10.1016/S0021-9150(00)00515-3 contributor: fullname: Johnson – volume: 129 start-page: 399 issue: 3 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib1 article-title: Executive summary: heart disease and stroke statistics—2014 update: a report from the American heart association publication-title: Circulation doi: 10.1161/01.cir.0000442015.53336.12 contributor: fullname: Go – volume: 105 start-page: 1049 issue: 8 year: 2000 ident: 10.1016/j.atherosclerosis.2016.03.013_bib51 article-title: Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice publication-title: J. Clin. Invest. doi: 10.1172/JCI9259 contributor: fullname: Febbraio – volume: 364 start-page: 226 issue: 3 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib20 article-title: A prospective natural-history study of coronary atherosclerosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1002358 contributor: fullname: Stone – volume: 190 start-page: 239 issue: 2 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib73 article-title: ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.03.007 contributor: fullname: Terasaka – volume: 129 start-page: 93 issue: 2 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib31 article-title: Cellular and molecular mechanisms of statins: an update on pleiotropic effects publication-title: Clin. Sci. (Lond) doi: 10.1042/CS20150027 contributor: fullname: Satoh – volume: 96 start-page: 6920 issue: 12 year: 1999 ident: 10.1016/j.atherosclerosis.2016.03.013_bib62 article-title: Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.96.12.6920 contributor: fullname: Caligiuri – volume: 98 start-page: 815 issue: 3 year: 1996 ident: 10.1016/j.atherosclerosis.2016.03.013_bib44 article-title: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein publication-title: J. Clin. Invest. doi: 10.1172/JCI118854 contributor: fullname: Horkko – volume: 46 start-page: 517 issue: 4 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib56 publication-title: Eur. J. Cardio-Thoracic Surg. doi: 10.1093/ejcts/ezu366 contributor: fullname: Kolh – volume: 357 start-page: 2109 issue: 21 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib76 article-title: Effects of torcetrapib in patients at high risk for coronary events publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0706628 contributor: fullname: Barter – volume: 73 start-page: 453 issue: 3 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib87 article-title: Targeting the heart with gene therapy-optimized gene delivery methods publication-title: Cardiovasc. Res. doi: 10.1016/j.cardiores.2006.09.021 contributor: fullname: Muller – volume: 71 start-page: 343 issue: 2 year: 1992 ident: 10.1016/j.atherosclerosis.2016.03.013_bib36 article-title: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells publication-title: Cell doi: 10.1016/0092-8674(92)90362-G contributor: fullname: Plump – volume: 268 start-page: 10540 issue: 14 year: 1993 ident: 10.1016/j.atherosclerosis.2016.03.013_bib58 article-title: Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)82232-3 contributor: fullname: van den Maagdenberg – volume: 2 start-page: 126 issue: 5 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib40 article-title: Animal models of atherosclerosis publication-title: World J. Clin. Cases doi: 10.12998/wjcc.v2.i5.126 contributor: fullname: Kapourchali – volume: 4 start-page: e7037 issue: 9 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.013_bib85 article-title: Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease publication-title: PLoS One doi: 10.1371/journal.pone.0007037 contributor: fullname: Sinnaeve – volume: 162 start-page: 597 issue: 4 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib19 article-title: Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) publication-title: Am. Heart J. doi: 10.1016/j.ahj.2011.06.012 contributor: fullname: Ridker – volume: 121 start-page: 2693 issue: 7 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib78 article-title: Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease publication-title: J. Clin. Invest doi: 10.1172/JCI42946 contributor: fullname: Besler – volume: 115 start-page: 2072 issue: 8 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.013_bib55 article-title: You are right too! publication-title: J. Clin. Invest. doi: 10.1172/JCI26130 contributor: fullname: Witztum – volume: 123 start-page: e18 issue: 4 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib2 article-title: Disease and stroke statistics writing group: heart disease and stroke statistics–2011 update: a report from the American heart association publication-title: Circulation doi: 10.1161/CIR.0b013e3182009701 contributor: fullname: Roger – volume: 89 start-page: 4471 issue: 10 year: 1992 ident: 10.1016/j.atherosclerosis.2016.03.013_bib35 article-title: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.89.10.4471 contributor: fullname: Piedrahita – volume: 371 start-page: 1761 issue: 9626 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.013_bib74 article-title: Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(08)60763-1 contributor: fullname: Tardif – volume: 20 start-page: 271 issue: 5 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib88 article-title: Nanomedicine-based strategies for treatment of atherosclerosis publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2013.12.001 contributor: fullname: Schiener – volume: 111 start-page: 1422 issue: 11 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.013_bib68 article-title: Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment publication-title: Circulation doi: 10.1161/01.CIR.0000158435.98035.8D contributor: fullname: Johnson – volume: 372 start-page: 2387 issue: 25 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib32 article-title: Ezetimibe added to statin therapy after acute coronary syndromes publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1410489 contributor: fullname: Cannon – volume: 19 start-page: 1166 issue: 9 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib46 article-title: Local proliferation dominates lesional macrophage accumulation in atherosclerosis publication-title: Nat. Med. doi: 10.1038/nm.3258 contributor: fullname: Robbins – volume: 168 start-page: 5126 issue: 6 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib79 article-title: High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2013.07.113 contributor: fullname: Koenig – volume: 302 start-page: 37 issue: 1 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.013_bib17 article-title: GEnetic loci associated with c-reactive protein levels and risk of coronary heart disease publication-title: JAMA doi: 10.1001/jama.2009.954 contributor: fullname: Elliott – volume: 24 start-page: 1006 issue: 6 year: 2004 ident: 10.1016/j.atherosclerosis.2016.03.013_bib38 article-title: Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000128849.12617.f4 contributor: fullname: Meir – volume: 21 start-page: 434 issue: 5 year: 2010 ident: 10.1016/j.atherosclerosis.2016.03.013_bib60 article-title: Atherosclerotic lesions in mouse and man: is it the same disease? publication-title: Curr. Opin. Lipidol. doi: 10.1097/MOL.0b013e32833ded6a contributor: fullname: Bentzon – volume: 487 start-page: 325 issue: 7407 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.013_bib63 article-title: Myocardial infarction accelerates atherosclerosis publication-title: Nature doi: 10.1038/nature11260 contributor: fullname: Dutta – volume: 319 start-page: 24 issue: 1 year: 1988 ident: 10.1016/j.atherosclerosis.2016.03.013_bib29 article-title: HMG-CoA reductase inhibitors for treatment of hypercholesterolemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198807073190105 contributor: fullname: Grundy – volume: 24 start-page: 419 issue: 5 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib42 article-title: Mouse models of plaque rupture publication-title: Curr. Opin. Lipidol. doi: 10.1097/MOL.0b013e3283646e4d contributor: fullname: Matoba – volume: 17 start-page: 1410 issue: 11 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib49 article-title: Atherosclerosis: current pathogenesis and therapeutic options publication-title: Nat. Med. doi: 10.1038/nm.2538 contributor: fullname: Weber – volume: 111 start-page: 562 issue: 3 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib48 article-title: Platelet-derived PF4 reduces neutrophil apoptosis following arterial occlusion publication-title: Thromb. Haemost. doi: 10.1160/TH13-08-0699 contributor: fullname: Hartwig – volume: 72 start-page: 323 issue: 2 year: 1976 ident: 10.1016/j.atherosclerosis.2016.03.013_bib28 article-title: Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity publication-title: FEBS Lett. doi: 10.1016/0014-5793(76)80996-9 contributor: fullname: Endo – volume: 15 start-page: 551 issue: 5 year: 1995 ident: 10.1016/j.atherosclerosis.2016.03.013_bib11 article-title: The response-to-retention hypothesis of early atherogenesis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.15.5.551 contributor: fullname: Williams – volume: 29 start-page: 19 issue: 1 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.013_bib54 article-title: Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.108.176644 contributor: fullname: Manning-Tobin – volume: 32 start-page: 2372 issue: 10 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.013_bib69 article-title: Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.111.236158 contributor: fullname: Jin – volume: 103 start-page: 181 issue: 2 year: 1981 ident: 10.1016/j.atherosclerosis.2016.03.013_bib9 article-title: The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions publication-title: Am. J. Pathol. contributor: fullname: Gerrity – volume: 27 start-page: 165 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.013_bib6 article-title: Immune and inflammatory mechanisms of atherosclerosis (*) publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.021908.132620 contributor: fullname: Galkina – volume: 367 start-page: 2089 issue: 22 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.013_bib77 article-title: Effects of dalcetrapib in patients with a recent acute coronary syndrome publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1206797 contributor: fullname: Schwartz – volume: 19 start-page: 5963 issue: 33 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib84 article-title: The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development publication-title: Curr. Pharm. Des. doi: 10.2174/13816128113199990365 contributor: fullname: Puri – volume: 34 start-page: 2949 issue: 38 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib25 article-title: 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht296 contributor: fullname: Task Force – volume: 93 start-page: 1403 issue: 4 year: 1994 ident: 10.1016/j.atherosclerosis.2016.03.013_bib57 article-title: Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice publication-title: J. Clin. Invest doi: 10.1172/JCI117117 contributor: fullname: van Vlijmen – volume: 312 start-page: 1006 issue: 10 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib16 article-title: Effect of darapladib on major coronary events after an acute coronary syndrome: the solid-timi 52 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2014.11061 contributor: fullname: O'Donoghue – volume: 92 start-page: 883 issue: 2 year: 1993 ident: 10.1016/j.atherosclerosis.2016.03.013_bib37 article-title: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery publication-title: J. Clin. Invest. doi: 10.1172/JCI116663 contributor: fullname: Ishibashi – volume: 5 start-page: 291 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib81 article-title: Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification publication-title: Front. Physiol. doi: 10.3389/fphys.2014.00291 contributor: fullname: Korosoglou – volume: 132 start-page: 1224 issue: 13 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib13 article-title: Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of Ezetimibe to Simvastatin and associated with better outcomes in IMPROVE-IT publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.018381 contributor: fullname: Bohula – volume: 370 start-page: 1702 issue: 18 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib15 article-title: Darapladib for preventing ischemic events in stable coronary heart disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1315878 – volume: 103 start-page: 191 issue: 2 year: 1981 ident: 10.1016/j.atherosclerosis.2016.03.013_bib8 article-title: The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions publication-title: Am. J. Pathol. contributor: fullname: Gerrity – volume: 115 start-page: 2192 issue: 8 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.013_bib53 article-title: Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice publication-title: J. Clin. Invest. doi: 10.1172/JCI24061 contributor: fullname: Moore – volume: 92 start-page: 8264 issue: 18 year: 1995 ident: 10.1016/j.atherosclerosis.2016.03.013_bib43 article-title: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.92.18.8264 contributor: fullname: Smith – volume: 50 start-page: 276 issue: 2 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib22 article-title: Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.107.089854 contributor: fullname: Gleissner – volume: 173 start-page: 6403 issue: 10 year: 2004 ident: 10.1016/j.atherosclerosis.2016.03.013_bib64 article-title: Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains publication-title: J. Immunol. doi: 10.4049/jimmunol.173.10.6403 contributor: fullname: Schenkel – volume: 539 start-page: 81 issue: 1–2 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.013_bib75 article-title: Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2006.03.078 contributor: fullname: Kitayama – volume: 29 start-page: 149 issue: 2 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib24 article-title: Induction of dendritic cell-like phenotype in macrophages during foam cell formation publication-title: Physiol. Genom. doi: 10.1152/physiolgenomics.00051.2006 contributor: fullname: Cho – volume: 110 start-page: 3507 issue: 9 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib66 article-title: Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases publication-title: Proc. Natl. Acad. Sci. U S A. doi: 10.1073/pnas.1222878110 contributor: fullname: Seok – volume: 36 start-page: 2415 issue: 36 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib33 article-title: PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehv174 contributor: fullname: Shimada – volume: 51 start-page: 1440 issue: 15 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.013_bib59 article-title: Lipid levels after acute coronary syndromes publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2007.11.075 contributor: fullname: Pitt – volume: 24 start-page: 439 issue: 3 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.013_bib83 article-title: Evaluation of collagen in atherosclerotic plaques: the use of two coherent laser-based imaging methods publication-title: Lasers Med. Sci. doi: 10.1007/s10103-007-0535-x contributor: fullname: Nadkarni – volume: 115 issue: 3 year: 2010 ident: 10.1016/j.atherosclerosis.2016.03.013_bib65 article-title: Comparison of gene expression profiles between human and mouse monocyte subsets publication-title: Blood doi: 10.1182/blood-2009-07-235028 contributor: fullname: Ingersoll – volume: 353 start-page: 93 issue: 1 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.013_bib21 article-title: Intensive lipid lowering with atorvastatin in coronary disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200507073530117 contributor: fullname: Cannon – volume: 171 start-page: 326 issue: 1 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib86 article-title: Distinctive expression of chemokines and transforming growth factor-β Signaling in human arterial endothelium during atherosclerosis publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2007.061196 contributor: fullname: Volger – volume: 359 start-page: 2195 issue: 21 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.013_bib12 article-title: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0807646 contributor: fullname: Ridker – volume: 20 start-page: 2593 issue: 12 year: 2000 ident: 10.1016/j.atherosclerosis.2016.03.013_bib50 article-title: Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.20.12.2593 contributor: fullname: Babaev – volume: 33 start-page: 1635 issue: 13 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.013_bib26 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehs092 contributor: fullname: Perk – volume: 45 start-page: 1429 issue: 5 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib5 article-title: Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients publication-title: Stroke doi: 10.1161/STROKEAHA.113.004229 contributor: fullname: Sirimarco – volume: 11 start-page: 3061 issue: 23 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.013_bib23 article-title: Macrophage differentiation to foam cells publication-title: Curr. Pharm. Des. doi: 10.2174/1381612054865064 contributor: fullname: Shashkin – volume: 78 start-page: 185 issue: 1 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.013_bib52 article-title: Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvm093 contributor: fullname: Kuchibhotla – volume: 15 start-page: 295 issue: 1 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib4 article-title: Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-012-0295-3 contributor: fullname: Ridker – volume: 10 start-page: e0141019 issue: 10 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib70 article-title: Atherosclerotic plaque destabilization in mice: a comparative study publication-title: PLoS One doi: 10.1371/journal.pone.0141019 contributor: fullname: Hartwig – volume: 27 start-page: 1706 issue: 8 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.013_bib39 article-title: Mouse models for atherosclerosis and pharmaceutical modifiers publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.107.142570 contributor: fullname: Zadelaar – volume: 9 start-page: 61 issue: 1 year: 2003 ident: 10.1016/j.atherosclerosis.2016.03.013_bib45 article-title: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E publication-title: Nat. Med. doi: 10.1038/nm810 contributor: fullname: Huo – volume: 14 start-page: 1 issue: 1 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.013_bib3 article-title: Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-011-0219-7 contributor: fullname: Sampson – volume: 87 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib72 article-title: A human ex vivo atherosclerotic plaque model to study lesion biology publication-title: J. Vis. Exp. contributor: fullname: Erbel – volume: 47 start-page: 859 issue: 4 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib80 article-title: Computational approaches for analyzing the mechanics of atherosclerotic plaques: a review publication-title: J. Biomech. doi: 10.1016/j.jbiomech.2014.01.011 contributor: fullname: Holzapfel – volume: 86 start-page: 1372 issue: 4 year: 1989 ident: 10.1016/j.atherosclerosis.2016.03.013_bib10 article-title: Low density lipoprotein undergoes oxidative modification in vivo publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.86.4.1372 contributor: fullname: Palinski – volume: 34 start-page: 154 issue: 2 year: 2003 ident: 10.1016/j.atherosclerosis.2016.03.013_bib34 article-title: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia publication-title: Nat. Genet. doi: 10.1038/ng1161 contributor: fullname: Abifadel – ident: 10.1016/j.atherosclerosis.2016.03.013_bib14 – volume: 51 start-page: 809 year: 1856 ident: 10.1016/j.atherosclerosis.2016.03.013_bib7 article-title: Der atheromatöse Prozess der Arterien publication-title: Wien. Med. Wochenschr contributor: fullname: Virchow – volume: 76 start-page: e50332 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib71 article-title: An in vitro model to study heterogeneity of human macrophage differentiation and polarization publication-title: J. Vis. Exp. contributor: fullname: Erbel – volume: 22 start-page: 221 issue: 3 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib41 article-title: Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression publication-title: Vascular doi: 10.1177/1708538113478758 contributor: fullname: Millon – volume: 166 issue: 2 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.013_bib18 article-title: Rationale and design of the cardiovascular inflammation reduction trial (CIRT): A test of the inflammatory hypothesis of atherothrombosis publication-title: Am. heart J. doi: 10.1016/j.ahj.2013.03.018 contributor: fullname: Everett – volume: 22 start-page: 18 issue: 1 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib27 article-title: All for statins and statins for all; an update publication-title: Curr. Pharm. Des. doi: 10.2174/1381612822666151109111511 contributor: fullname: Agouridis – volume: 364 start-page: 226 issue: 3 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.013_bib61 article-title: A prospective natural-history study of coronary atherosclerosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1002358 contributor: fullname: Stone – volume: 64 start-page: 207 issue: 2 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.013_bib82 article-title: Clinical utility of intravascular imaging and physiology in coronary artery disease publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2014.01.015 contributor: fullname: Mintz – volume: 36 start-page: 1049 issue: 17 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.013_bib47 article-title: Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehu041 contributor: fullname: Van der Donckt – volume: 2 start-page: 517 issue: 7 year: 2003 ident: 10.1016/j.atherosclerosis.2016.03.013_bib30 article-title: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1112 contributor: fullname: Tobert |
SSID | ssj0004718 |
Score | 2.3151748 |
SecondaryResourceType | review_article |
Snippet | Abstract Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress... Atherosclerosis is the leading cause of death worldwide. Research on the pathophysiological mechanisms of atherogenesis has made tremendous progress over the... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 110 |
SubjectTerms | Animals Atherosclerosis Atherosclerosis - physiopathology Atherosclerosis - therapy Cardiology - methods Cardiovascular Clinical trials Clinical Trials as Topic Coronary artery disease Coronary Artery Disease - physiopathology Coronary Artery Disease - therapy Disease Models, Animal Humans Metabolic Syndrome - complications Mice Mice, Transgenic Personalized medicine Precision Medicine - methods Therapy Translational Medical Research - methods Treatment Outcome |
Title | Translational atherosclerosis research: From experimental models to coronary artery disease in humans |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0021915016300880 https://dx.doi.org/10.1016/j.atherosclerosis.2016.03.013 https://www.ncbi.nlm.nih.gov/pubmed/26999293 https://search.proquest.com/docview/1782216430 |
Volume | 248 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50BfEivl1fRNBjtWnSx3pSxGVV1pOCt5CmCa5ou2x3D3vxtztpUx8rguCl0JY0k8lk5kvnEYAjziRF1GA8plns8TRSXpowhbtWw6jGNzqzucP9u6j3wG8ew8c5uGxyYWxYpdP9tU6vtLV7cuq4eTocDGyOL642xDPUVo1CMZyHBTRHQdKChYvr297dZ3pkTGuFbKMRsMEiHH-GeVU4qyjxq3gd2ALeNKrKnlL2m6n6DYpWJqm7AssOS5KLmtxVmNP5Giz2nbd8HXRliF7c7z4yQwNxdX6ezkh3VLySr7X-SXVATknGBVG2xIEcTUkV_DklzqNDBjmpzvcrN-Che3V_2fPcsQqe4pyPvUCi1c90rCIEO7ITBCm3IKZDkXmhNCpITeaHqfGlCpLQ-JniYZaYDpdSmo40bBNaeZHrbSChTqRkmcp8X3EVh9K6dVMpNTdKYbs2RA0HxbCuniGasLJnMTNsYVkvfCaQ9W2IG36LJkUUlZou3QorBRVlIHzxQwracP7R8psgCbQRf-38sJlhgYvNelBkrosJdmrxFG4wGXazVU_9x7iCCLE2gqed_xOwC0v2ro6r3IPWeDTR-4h9xukBzJ-80QMn4e-ynQji |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LS8MwGP_QCepFfDufEfRYbJu0XT0p4piP7TTBW0jTBCfajnU77L_3S5vOFwPBSw8NaZIv3-OXfo8AnDEqPEQN2qGKRg5LQukkLSrx1Kqpp7BFpSZ3uNsLO0_s_jl4XoCbOhfGhFVa3V_p9FJb2zcXlpoXw8HA5PiitCGe8UzVKGTDRVhCNBCjdC5d3z10ep_pkZFXKWQTjYAdluH8M8yrxFl5gV_F58AU8PbCsuypR-eZqnlQtDRJ7XVYs1iSXFfT3YAFlW3Cctd6y7dAlYbozf7uIz_mQGydn5dL0h7l7-RrrX9SXpBTkHFOpClxIEZTUgZ_Ton16JBBRsr7_YpteGrf9m86jr1WwZGMsbHjC7T6qYpkiGBHxL6fMANiYo8h2BFa-olO3SDRrpB-K9BuKlmQtnTMhBA6FpruQCPLM7UHJFAtIWgqU9eVTEaBMG7dRAjFtJTYrwlhTUE-rKpn8Dqs7JX_WDY3pOcu5Uj6JkQ1vXmdIopKTRVWwgru8cLnLv_FBU24mvX8xkgcbcRfBz-td5ijsBkPishUPsFBDZ7CAybFYXarrZ-tyw8RayN42v__BE5gpdPvPvLHu97DAayalirG8hAa49FEHSEOGifHls8_ABh7CtY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Translational+atherosclerosis+research%3A+From+experimental+models+to+coronary+artery+disease+in+humans&rft.jtitle=Atherosclerosis&rft.au=Gleissner%2C+Christian+A&rft.date=2016-05-01&rft.eissn=1879-1484&rft.volume=248&rft.spage=110&rft.epage=116&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2016.03.013&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9150&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9150&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9150&client=summon |